Blog

A $5 billion Silicon Valley VC is getting back into biotech and looking to back ‘iconic entrepreneurs’ – Business Insider


Business Insider

A $5 billion Silicon Valley VC is getting back into biotech and looking to back 'iconic entrepreneurs'
Business Insider
Specifically, the plan will be to invest in companies that are in diagnostics, genomics, digital health, synthetic biology, and have a data-driven platforms for drug discovery. So far, Menlo has invested in Synthego, Cofactor Genomics, Clear Labs
Menlo Ventures banks on tech-driven life sciences, adds Greg Yap as new partnerVentureBeat


Menlo Ventures adds Greg Yap as Partner to Focus on Life Science Technology InvestingGlobeNewswire (press release)

all 3 news articles »

2017-10-10 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.